Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis - Yahoo Finance

Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis  Yahoo Finance

Roche's (RHHBY) lymphoma drug, Gazyva, obtains Breakthrough Therapy designation in the United States for lupus nephritis.